S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSE:HLN

Haleon (HLN) Stock Price, News & Analysis

$8.49
-0.04 (-0.47%)
(As of 03/28/2024 ET)
Today's Range
$8.49
$8.58
50-Day Range
$8.03
$8.65
52-Week Range
$7.70
$9.05
Volume
4.38 million shs
Average Volume
9.15 million shs
Market Capitalization
$39.22 billion
P/E Ratio
30.34
Dividend Yield
2.47%
Price Target
N/A

Haleon MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.45% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.54mentions of Haleon in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.51%
From $0.47 to $0.51 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.26 out of 5 stars

Medical Sector

575th out of 938 stocks

Drug Manufacturers - Specialty & Generic Industry

3rd out of 3 stocks

HLN stock logo

About Haleon Stock (NYSE:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

HLN Stock News Headlines

Haleon (NYSE:HLN) Given Buy Rating at Argus
Stocks Making Big Moves Today
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Pfizer Plans To Sell About 630 Mln Haleon Shares
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Haleon plc (HLN) Q4 2023 Earnings Call Transcript
Haleon plc 2023 Q4 - Results - Earnings Call Presentation
Zoetis Inc. (ZTS)
1 Pharma Stock to Buy Near 52-Week Highs
GSK to sell 3.2% stake in spin-off Haleon
See More Headlines
Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/16 Dividend
3/14/2024
Today
3/29/2024
Next Earnings (Estimated)
5/01/2024
Dividend Payable
5/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Toilet preparations
Sub-Industry
N/A
Fax
N/A
Employees
25,408
Year Founded
N/A

Profitability

Net Income
$1.30 billion
Pretax Margin
14.40%

Debt

Sales & Book Value

Annual Sales
$14.05 billion
Cash Flow
$0.36 per share
Book Value
$4.51 per share

Miscellaneous

Outstanding Shares
4,617,290,000
Free Float
N/A
Market Cap
$39.22 billion
Optionable
Not Optionable
Beta
0.30
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Brian James McNamara (Age 58)
    CEO & Executive Director
    Comp: $4.28M
  • Mr. Tobias Hannes Hestler (Age 52)
    CFO & Executive Director
    Comp: $2.38M
  • Ms. Sonya Ghobrial (Age 50)
    Head of Investor Relations
  • Mr. Bjarne Philip Tellmann (Age 57)
    General Counsel
  • Ms. Tamara Rogers (Age 54)
    Chief Marketing Officer
  • Ms. Mairead Nayager (Age 49)
    Chief Human Resources Officer
  • Mr. Filippo Lanzi
    President of EMEA & LatAm
  • Mr. Keith Choy (Age 55)
    President of Asia Pacific
  • Ms. Lisa Paley (Age 57)
    President of North America
  • Mr. Franck Riot (Age 56)
    Chief R&D Officer

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Haleon plc:

  • Haleon plc engages in the research, development, manufacture, and sale of various consumer healthcare products globally, providing a diversified revenue stream.
  • The company offers a portfolio of well-known brands like Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum, which have strong market presence and consumer trust.
  • Haleon plc recently announced a semi-annual dividend with a yield of 1.8%, indicating a commitment to rewarding shareholders.
  • The company's stock price has shown stability and growth potential, with a 52-week low of $7.70 and a 52-week high of $9.05, reflecting positive market performance.
  • Haleon plc has a market capitalization of $38.05 billion, indicating a sizable presence in the consumer healthcare industry.

Cons

Investors should be bearish about investing in Haleon plc for these reasons:

  • The company's P/E ratio of 29.95 and P/E/G ratio of 2.62 may suggest the stock is currently overvalued, potentially limiting short-term gains for investors.
  • Haleon plc's debt-to-equity ratio of 0.53 indicates a moderate level of financial leverage, which could pose risks in times of economic downturns or rising interest rates.
  • The company's recent stock performance, trading down to $8.24 during mid-day trading, may raise concerns about short-term volatility and market sentiment.
  • While Haleon plc operates globally, exposure to multiple regions could subject the company to geopolitical risks, regulatory challenges, and currency fluctuations.
  • Investors should consider the competitive landscape in the consumer healthcare industry, as Haleon plc faces competition from other established players and potential disruptors in the market.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, March 25, 2024. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

HLN Stock Analysis - Frequently Asked Questions

Should I buy or sell Haleon stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HLN shares.
View HLN analyst ratings
or view top-rated stocks.

How have HLN shares performed in 2024?

Haleon's stock was trading at $8.23 at the start of the year. Since then, HLN shares have increased by 3.2% and is now trading at $8.4950.
View the best growth stocks for 2024 here
.

Are investors shorting Haleon?

Haleon saw a increase in short interest in March. As of March 15th, there was short interest totaling 20,810,000 shares, an increase of 45.3% from the February 29th total of 14,320,000 shares. Based on an average daily trading volume, of 5,360,000 shares, the days-to-cover ratio is presently 3.9 days. Approximately 0.5% of the company's stock are sold short.
View Haleon's Short Interest
.

When is Haleon's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our HLN earnings forecast
.

How often does Haleon pay dividends? What is the dividend yield for Haleon?

Haleon announced a semi-annual dividend on Thursday, February 29th. Shareholders of record on Friday, March 15th will be paid a dividend of $0.1064 per share on Thursday, May 16th. This represents a yield of 1.8%. The ex-dividend date of this dividend is Thursday, March 14th.
Read our dividend analysis for HLN
.

Is Haleon a good dividend stock?

Haleon (NYSE:HLN) pays an annual dividend of $0.21 per share and currently has a dividend yield of 2.52%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 75.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HLN will have a dividend payout ratio of 41.18% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HLN.

What ETFs hold Haleon's stock?
Who are Haleon's major shareholders?

Haleon's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Dodge & Cox (2.40%), Clearbridge Investments LLC (0.58%), Harding Loevner LP (0.48%), Fisher Asset Management LLC (0.32%), Fisher Asset Management LLC (0.32%) and Wellington Management Group LLP (0.29%).

How do I buy shares of Haleon?

Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:HLN) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners